Partha Karmakar
Affiliations: | 2015-2016 | Biochemistry and Molecular Biophysics | Washington University, Saint Louis, St. Louis, MO |
Google:
"Partha Karmakar"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Steven J. Sucheck | grad student | 2010-2015 | The University of Toledo |
| James W. Janetka | post-doc | 2015-2016 | Washington University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mahoney M, Damalanka VC, Tartell MA, et al. (2021) A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Mahoney M, Damalanka VC, Tartell MA, et al. (2021) A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Biorxiv : the Preprint Server For Biology |
| Muz B, Puente Pdl, Shah S, et al. (2020) Abstract A27: Endothelial progenitor cells as drug-delivery Trojan horses for treatment and imaging of cancer Cancer Immunology Research. 8 |
| Karmakar P, Gaitonde V. (2019) Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines (Basel, Switzerland). 6 |
| Damalanka VC, Han Z, Karmakar P, et al. (2018) Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology. Journal of Medicinal Chemistry |
| Hossain MK, Vartak A, Karmakar P, et al. (2018) Augmenting vaccine immunogenicity through the use of natural human anti-rhamnose antibodies. Acs Chemical Biology |
| Kotagiri N, Cooper ML, Rettig M, et al. (2018) Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer. Nature Communications. 9: 275 |
| Han Z, Harris PK, Karmakar P, et al. (2016) α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer. Chemmedchem |
| Liu F, Han Z, Karmakar P, et al. (2016) DDIS-10. TARGETING HGF/MET IN GBM BY RESTORING SPINT2 FUNCTION Neuro-Oncology. 18: vi49-vi49 |
| Han Z, Harris PKW, Karmakar P, et al. (2016) Back Cover: α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer (ChemMedChem 6/2016) Chemmedchem. 11: 640-640 |